학술논문
A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib
Document Type
Article
Author
Source
In Annals of Oncology January 2014 25(1):236-240
Subject
Language
ISSN
0923-7534